Location Greater Boston Area, United States, North America Regions East Coast, New England Gender Male
LinkedIn View on LinkedIn
John McDonough joined T2 Biosystems in 2007.
Prior to joining T2 Bio, John was President of Cytyc Development Corporation and had responsibility for designing and executing Cytyc Corporation’s acquisition and investment strategy for growing the company from a single product company with revenue of approximately $300 million in 2003, to a
company with revenue of approximately $750 million from multiple products in 2007. In total, Cytyc acquired five companies totaling over $1 billion in acquisitions and also entered into alliances and investments with several early stage companies. John led the efforts that resulted in Cytyc’s acquisition by Hologic, Inc. in October, 2007, for over $6 billion, representing almost a four times increase in Cytyc’s market cap over a four year period. During John’s tenure at Cytyc, he also had responsibility for Cytyc’s Research & Development, Operations and Regulatory functions.
John came to Cytyc after serving as co-founder, CEO and president at SoundBite Communications, a customer communications company which went public in 2007. Previously, he was COO of Direct Hit Technologies, an Internet search engine company that was successfully acquired in January, 2000, for over $500 million, and CEO and President of Workgroup Technology, a publicly held company that developed and marketed product development management solutions. John also spent 10 years with Easel Corporation where he held the role of CFO, COO and then CEO of a start-up company that grew into a publicly held company in 1990 and which was acquired in 1995.
John is currently a member of the Board of Directors for Solace Therapeutics, a medical device company focused on the development of non-surgical, office based treatments for common bladder disorders. John was a member of the Board of Directors for Interlace Medical, a developer of medical devices for treating gynecological diseases, which was acquired by Hologic, Inc. in January, 2011. John was also a member of the Board of Directors of CRi, a developer of optical imaging systems for biomedical research and molecular-based drug and diagnostic development. CRi was acquired by Caliper Life Sciences in December, 2010.
John graduated Magna Cum Laude from Stonehill College in 1981.
